Burns, T, Yeeles, K, Molodynski, A, Nightingale, H, Vazquez-Montes, M, Sheehan, K, et al. Pressures to adhere to treatment (‘leverage’) in English mental healthcare. Br J Psychiatry
2011; 199: 145–50.
Gilburt, H, Slade, M, Rose, D, Lloyd-Evans, B, Johnson, S, Osborn, DPJ. Service users' experiences of residential alternatives to standard acute wards: qualitative study of similarities and differences. Br J Psychiatry
2010 (suppl 53); 197: s26–31.
Pope, A, Adams, C, Paton, C, Weaver, T, Barnes, TRE. Assessment of adverse effects in clinical studies of antipsychotic medication: survey of methods used. Br J Psychiatry
2010; 197: 67–72.
Tyrer, P, Kendall, T. The spurious advance of antipsychotic drug therapy. Lancet
2009; 373: 4–5.
Mendel, R, Hamann, J, Traut-Mattausch, E, Bühner, M, Kissling, W, Frey, D. ‘What would you do if you were me, doctor?’: randomized trial of psychiatrists' personal v. professional perspectives on treatment recommendations. Br J Psychiatry
2010; 197: 441–7.
Young, AH, Oren, DA, Lowy, A, McQuade, RD, Marcus, RN, Carson, WH, et al. Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study. Br J Psychiatry
2009; 194: 40–8.
Craddock, N, Antebi, D, Attenburrow, MJ, Bailey, A, Carson, A, Cowen, P, et al. Wake-up call for British psychiatry. Br J Psychiatry
2008; 193: 6–9.
Friis, S. Early specialised treatment for first-episode psychosis; does it make a difference?
Br J Psychiatry
2010; 196: 339–40.
McCrone, P, Craig, TKJ, Power, P, Garety, PA. Cost-effectiveness of an early intervention service for people with psychosis. Br J Psychiatry
2010; 196: 377–82.
Olatunji, BO, Deacon, BJ, Abramowitz, JS. Is hypochondriasis an anxiety disorder?
Br J Psychiatry
2009; 194: 481–2.